Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Galderma Nordic AB
AB
Active
Org 5565620928
Fyrisvallsgatan 7 A, 752 28
Uppsala
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 1998 · 27 years old
34 employees
Monitor
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Galderma Nordic AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
538M
403M
269M
134M
0M
2021: 322M
322M
2021
2022: 327M (+2% vs 2021)
327M
+2%
2022
2023: 371M (+13% vs 2022)
371M
+13%
2023
2024: 376M (+1% vs 2023)
376M
+1%
2024
2025: 432M (+15% vs 2024)
432M
+15%
2025
EBITDA
SEK millions
16M
12M
8M
4M
0M
2021: 13M
13M
2021
2022: 9M (-31% vs 2021)
9M
-31%
2022
2023: 10M (+11% vs 2022)
10M
+11%
2023
2024: 10M (0% vs 2023)
10M
0%
2024
2025: 10M (0% vs 2024)
10M
0%
2025
Income statement
SEK thousands
Item
2025
2024
2023
2022
2021
Revenue
432 208
375 585
371 250
327 163
322 372
Staff expenses
−63 926
—
—
—
—
EBITDA
9 900
9 593
9 595
9 056
13 461
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
9 902
9 593
9 595
9 056
13 461
Net financials
−261
83
−494
−665
−4 190
Profit before tax
9 641
9 676
9 102
8 390
10 966
Tax
−2 597
−2 374
−3 357
−1 899
−2 145
Net profit
7 044
7 302
5 745
6 491
8 821
Balance sheet
SEK thousands
Item
2025
2024
2023
2022
2021
Total assets
229 695
155 978
125 657
126 194
130 058
Equity
58 698
51 654
44 352
38 607
32 116
Long-term debt
6 000
8 500
13 500
13 500
0
Short-term debt
164 997
95 824
67 805
74 087
97 942
Total debt
170 997
104 324
81 305
87 587
97 942
Financial ratios
5-year trend
EBITDA margin
2,3 %
This company
15,8 %
Market median
This company
Market median
85% below market
2021
2025
Equity ratio
25,6 %
This company
38,2 %
Market median
This company
Market median
33% below market
2021
2025
Return on equity
12,0 %
This company
18,4 %
Market median
This company
Market median
35% below market
2021
2025
Net profit margin
1,6 %
This company
8,1 %
Market median
This company
Market median
80% below market
2021
2025
Asset turnover
1,88×
This company
1,12×
Market median
This company
Market median
68% above market
2021
2025
Debt / equity
2,91×
This company
0,62×
Market median
This company
Market median
369% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on Galderma Nordic AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
